MYNZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 15:31):

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics...

Stats
Today's Volume	235 823
Average Volume	106 568
Market Cap	15.85M
EPS	$0 ( 2024-04-08 )
Next earnings date	( $-0.310 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.450
ATR14	$0.00900 (1.24%)

Volume Correlation

Long: 0.20 (neutral)

Short: 0.34 (neutral)

Signal:(55.76) Neutral

Mainz Biomed B.V. Correlation

10 Most Positive Correlations
BNDW	0.809
GLPI	0.807
SOHO	0.805
EWZS	0.801
TLT	0.801

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mainz Biomed B.V. Correlation - Currency/Commodity

-0.73
( moderate negative )

-0.70
( moderate negative )

0.00
( neutral )

-0.71
( moderate negative )

0.00
( neutral )

0.55
( weak )

Mainz Biomed B.V. Financials

Annual	2023
Revenue:	$895 479
Gross Profit:	$509 659 (56.91 %)
EPS:	$-1.620

FY	2023
Revenue:	$895 479
Gross Profit:	$509 659 (56.91 %)
EPS:	$-1.620

FY	2022
Revenue:	$529 877
Gross Profit:	$182 151 (34.38 %)
EPS:	$-1.870

FY	2021
Revenue:	$577 348
Gross Profit:	$177 622 (30.77 %)
EPS:	$-1.620

Financial Reports:

No articles found.

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.